Raymond James & Associates’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $679K | Sell |
143,328
-7,121
| -5% | -$33.8K | ﹤0.01% | 2911 |
|
|
2024
Q2 | $707K | Sell |
150,449
-1,400
| -0.9% | -$6.58K | ﹤0.01% | 2834 |
|
|
2024
Q1 | $690K | Sell |
151,849
-2,980
| -2% | -$13.5K | ﹤0.01% | 2838 |
|
|
2023
Q4 | $638K | Buy |
154,829
+8,729
| +6% | +$36K | ﹤0.01% | 2791 |
|
|
2023
Q3 | $628K | Buy |
146,100
+8,615
| +6% | +$37K | ﹤0.01% | 2729 |
|
|
2023
Q2 | $714K | Buy |
137,485
+33,203
| +32% | +$172K | ﹤0.01% | 2675 |
|
|
2023
Q1 | $709K | Buy |
104,282
+15,033
| +17% | +$102K | ﹤0.01% | 2670 |
|
|
2022
Q4 | $219K | Buy |
89,249
+71,818
| +412% | +$176K | ﹤0.01% | 3379 |
|
|
2022
Q3 | $58K | Buy |
17,431
+4,482
| +35% | +$14.9K | ﹤0.01% | 3646 |
|
|
2022
Q2 | $63K | Sell |
12,949
-165
| -1% | -$803 | ﹤0.01% | 3706 |
|
|
2022
Q1 | $99K | Buy |
+13,114
| New | +$99K | ﹤0.01% | 3770 |
|